Revexepride is a selective 5-HT4 receptor agonist and potential CYP3A4 inducer, developed for gastroesophageal reflux disease (GERD) research. It is utilized in both in vitro binding assays and in vivo models to study gastrointestinal motility and drug metabolism interactions.
Molecular Weight:
425.95
CAS Number:
[219984-49-3]
Formula:
C21H32ClN3O4
Target:
Cytochromes P450,Others,5-HT Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
